Priya, a research analyst at Westfork Bancorp, is investigating Amberfen Pharma's upcoming drug, Ambenax. She collects the following: (1) public Phase II results from the FDA website; (2) a nonmaterial, nonpublic observation from a primary care physician about slowing prescription refills; (3) a private tip from a lab technician that Phase III results, scheduled for next week, show a total failure; and (4) public patent expiration data for Amberfen’s existing portfolio. Priya compiles facts 1, 2, and 4 into a 'Mosaic Research File' and issues a 'Sell' recommendation. She then calls a high-net-worth client and mentions the lab technician's tip.